Skip to content

Transcultural Validation in French of the Systemic Lupus Activity Questionnaire (SLAQ) and the Lupus Quality Of Life (LupusQoL) Questionnaire

Transcultural Validation in French of the Systemic Lupus Activity Questionnaire (SLAQ) and the Lupus Quality Of Life (LupusQoL) Questionnaire

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02857452
Acronym
FRESH COLA
Enrollment
162
Registered
2016-08-05
Start date
2009-01-31
Completion date
Unknown
Last updated
2016-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lupus

Brief summary

The evaluation of lupus patients must include several approaches, in particular disease activity and quality of life. The Systemic Lupus Activity Questionnaire (SLAQ) is a validated self-questionnaire to evaluate disease activity. It has the advantage of being inexpensive, easy to use in large cohorts and has been used in several studies. It has never been validated in French. The Lupus Quality Of Life (LupusQoL) is a self-questionnaire to evaluate quality of life and is specific to systemic lupus erythematous; it was developed from interviews with patients. This tool, validated in a British population, has never been validated in French.

Interventions

OTHERSLA Questionnaire
OTHERLupus Qol Questionnaire

Sponsors

Centre Hospitalier Universitaire Dijon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients with lupus meeting the 1997 classification criteria of the American College of Rheumatology for systemic lupus erythematous. * Patients able to understand written and spoken French. * Patients who have been informed about the research

Exclusion criteria

* Severe mental retardation. * Any impairment of ability to understand making self-evaluation impossible. * Age \< 18 years. * Age \> 75 years.

Design outcomes

Primary

MeasureTime frame
Answers in French to the au Systemic Lupus Activity Questionnaire (SLAQ)Evolution of answers between D0, D15, M3 and M6

Secondary

MeasureTime frame
Answers in French to the Lupus Quality of Life (Lupus QoL) questionnaireEvolution of answers between D0, D15, M3 and M6

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026